tirzepatide 25mg Oral | Starts at $279/mo Most Successful Weight Loss Program. 25 mg of tirzepatide Tirzepatide

Medication eligibility and outcomes depend on individual clinical evaluation

Tirzepatide may offer more significant weight loss and improved glucose control compared to semaglutide, as it targets both GIP and GLP-1 receptors

GLP-1 (936) amide metabolite suppression of glucose production in isolated mouse hepatocytes

Theranostics 10 , 43084322 (2020)

Composition and Properties III

These studies have demonstrated that Tirzepatide's combination of GLP and GIP promotes insulin sensitivity, appetite suppression, and cyclic adenosine monophosphate (cAMP) metabolism significantly better than administering either single agent (GLP or GIP)